Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2017-12-13 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Hardman Research: Remodelled for growth
Regulatory Filings Classification · 1% confidence The document is very short (3259 characters) and primarily serves as an announcement or cover page for a research report titled "Hardman Research: Remodelled for growth" concerning Genedrive PLC. It explicitly states, "Please click here for the full report: [link]" and concludes with "This information is provided by RNS The company news service from the London Stock Exchange". This structure strongly indicates that the document itself is an announcement of a report's availability rather than the comprehensive report (like an ER or IR). Since it is a general announcement provided via the RNS service, and it doesn't fit the specific criteria for a Report Publication Announcement (RPA) which usually announces the release of a mandatory filing, the most appropriate fallback category is Regulatory Filings (RNS), as it is explicitly branded as an RNS item.
2017-12-13 English
Director/PDMR Shareholding
Remuneration Information Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states it is providing 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. This content details the granting of share options to directors and senior management, which falls under insider trading or director's dealing disclosures. The specific filing type that covers personal share transactions by directors and executives is 'Director's Dealing' (DIRS). Although it uses the RNS distribution system, the specific content dictates the classification over the general RNS fallback.
2017-12-07 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly mentions 'RNS Number : 8820X' and 'genedrive plc announces that at the Annual General Meeting, held in Manchester today, all resolutions proposed were duly passed.' This indicates an official announcement regarding the results of the Annual General Meeting (AGM). The definition for AGM Information (AGM-R) covers 'Presentations and materials shared during the Annual General Meeting (AGM)'. Since this is an announcement confirming the passing of resolutions at the AGM, AGM-R is the most appropriate classification, rather than DVA (which is specifically for the *results* of voting) or RPA (which is for announcing the *publication* of a report). Given the content is directly about the AGM proceedings, AGM-R is selected.
2017-11-29 English
genedrive plc awarded Innovate UK grant
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement. The content details the formal awarding of a grant (£600,000 from Innovate UK) to Genedrive PLC to support product development. This type of announcement, which is a specific corporate update regarding funding or development milestones, is best classified as a general Regulatory Filing (RNS) or potentially Capital/Financing Update (CAP). Since it is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA), and it is a formal announcement distributed via the RNS system, RNS is the most appropriate general category for non-standard corporate news. Given the short length and the nature of the announcement (a grant award, not a financing round or debt change), RNS is the safest classification, although CAP is a close secondary consideration. I will select RNS as it is a standard regulatory news service release.
2017-11-21 English
2017 Annual Report and AGM Notice
Report Publication Announcement Classification · 1% confidence The document is very short (2006 characters) and explicitly states that copies of the '2017 Annual Report and Notice of the 2017 Annual General Meeting have been posted to shareholders' and that copies 'may be found on the Company's website'. This structure—announcing the availability of official reports (Annual Report and AGM Notice) without containing the full content of those reports—fits the definition of a Report Publication Announcement (RPA). Although it mentions the AGM and Annual Report, the primary function of this specific filing is to announce the publication/posting of those documents, triggering the 'MENU VS MEAL' rule.
2017-11-17 English
Distribution agreement with Sysmex Asia Pacific
M&A Activity Classification · 1% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement. The content describes a significant business event: 'genedrive signs distribution agreement with Sysmex Asia Pacific Pte Ltd for HCV'. This is a corporate action announcement, not a full financial report (like 10-K or IR), an earnings release (ER), or a proxy statement. It is a general, material announcement released through the Regulatory Information Service (RNS). Since it details a commercial agreement and is explicitly marked with an RNS number, the most appropriate classification is 'Regulatory Filings' (RNS), as it is a general regulatory disclosure that doesn't fit the more specific categories like CAP (Capital/Financing Update) or TAR (M&A Activity).
2017-11-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.